Archives for August 27, 2008

← 2008

Israeli court rules against “disingenuous” Taro

By Gareth Macdonald

The Tel-Aviv District Court has found in favour of Sun Pharmaceuticals in its long running struggle to acquire Israeli drug and pharmaceutical ingredient maker Taro Pharmaceutical Industries.

Boehringer hooks up with Chinese API firm

By Gareth Macdonald

Boehringer Ingelheim has formed a strategic production alliance with Chinese manufacturer Hisoar, significantly expanding its worldwide API network.

Chiltern revamps early-phase clinical division

By Phil Taylor

Contract research organisation Chiltern International has finalised the reorganisation of its early-stage clinical development activities, following its acquisition of Drug Development Solutions in February.

Exclusive interview with Bilcare CSO Dr Praful Naik

India’s Bilcare unveils anti-counterfeiting system

By Phil Taylor

Executives in pharmaceutical companies tasked with implementing an anti-counterfeiting strategy already have a difficult job assessing a frankly bewildering array of technological solutions.

LGC adds digital PCR to its service offering

By Dr Matt Wilkinson

UK laboratory services firm LGC has brought the first BioMark system into the UK in order to accurately quantify rare gene sequences for its pharmaceutical customers.

Codexis and Arch prepare for generic Lipitor market

By Gareth Macdonald

Codexis and Arch Pharmalabs’ expanded supply and development deal will see the latter produce APIs used in the manufacture of atorvastatin, principal component of Pfizer’s cholesterol buster Lipitor.